Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure

NCT00400985 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.

NCT NCT00400985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00400985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2005
Completion date
August 31, 2009
Enrollment
501 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, congestive